← FDA Drug Approvals (Drugs@FDA)
INVOKANA
NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2013-03-29
Drug application
- FDA Application #
NDA204042- Application type
- New Drug Application
- Brand name
- INVOKANA
- Generic name
- CANAGLIFLOZIN
- Active ingredients
- CANAGLIFLOZIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- JANSSEN PHARMS
- Manufacturer
- Janssen Pharmaceuticals, Inc.
- First approval
- 2013-03-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown